OPENING REMARKS : MESSAGE FROM THE PRESIDENT (TC-102)

Saturday, October 28, 2023

09:20 – 09:45 EST

Location: Palais, 519AB

Presenter(s)

Marie-Pier Arsenault, MD, MSc, FRCPC, DRCPSC (she/her/hers)

Physician
Hôpital Maisonneuve-Rosemont, Université de Montréal
Université de Montréal
Marc Carrier, MD, FRCPC, MSc

Physician
Ottawa Hospital
University of Ottawa
Siraj Mithoowani, MD, MHPE, FRCPC

Hematologist
McMaster University
McMaster University

Disclosure(s):

Marie-Pier Arsenault, MD, MSc, FRCPC, DRCPSC: Thrombose Canada: Speaker/Honoraria (Ongoing)

Marc Carrier, MD, FRCPC, MSc: Bayer: Speaker/Honoraria (Ongoing); BMS: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Leo Pharma: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Servier: Speaker/Honoraria (Ongoing)

Siraj Mithoowani, MD, MHPE, FRCPC: UpToDate: Speaker/Honoraria (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

apply current evidence in the management of patients with venous and arterial thrombotic disease;
manage challenging thrombosis clinical cases with a multidisciplinary team; and
prevent and treat venous thromboembolism in a variety of patient populations.